Skip to main content

Wave Life Sciences, Inc.

WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001631574

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Q1 2023 vs. Q4 2022

How the institutions holding Wave Life Sciences, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of WVE: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders7573−2
Shares68.1M70.1M+1.92M (+2.8%)
Value$476.9M$303.5M−$173.4M (−36.4%)

New holders (13)

Institutions that held Wave Life Sciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to WVE in Q1 2023
InstitutionSharesValue% of portfolio
HRT Financial LP233,278$1.01M0.01%
Verition Fund Management LLC54,841$237.5K0.00%
LMR Partners LLP39,459$170.9K0.00%
Diametric Capital, LP25,011$108.3K0.05%
Y-Intercept (Hong Kong) Ltd21,667$93.8K0.01%
Squarepoint Ops LLC18,972$82.1K0.00%
Point72 Middle East FZE12,601$54.6K0.00%
Jefferies Financial Group Inc.11,801$51.1K0.00%
Schonfeld Strategic Advisors LLC11,200$48.5K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)3,192$13.8K0.00%
TCI Wealth Advisors, Inc.295$1.28K0.00%
Lindbrook Capital, LLC150$6500.00%
Parallel Advisors, LLC95$4110.00%

Sold out (15)

Institutions that held Wave Life Sciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.